The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mack Gene since 2024.
This trader's CIK number is 1737979.
At the time of last reporting, Mack Gene was the CFO and Interim CEO of Gain Therapeutics, Inc.. (stock ticker symbol GANX).
Also see all insider trading activities at Gain Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | GANX | 14,400 | $14,544 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-09 | GANX | Buy | 14,400 | 1.01 | 14,544 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mack Gene (CFO and Interim CEO of Gain Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.